BPC-157 + TB-500 Recovery Stack
Safety Advisory
Research suggests potential interactions with angiogenic pathways. Not recommended for subjects with active malignancy.
Protocol Description
A common research combination. Standard research protocols often cite BPC-157 at 250mcg to 500mcg twice daily, paired with TB-500 at 2mg to 5mg weekly (divided into 2 doses).
Community Logs
0 VERIFIED ENTRIESNo logs recorded for this protocol yet.
Be the first to contribute data.